Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinomaOlga Kondrashova, L. Green, Robert Holian et al.|Nature Communications|2018Cited by 299
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Goli Samimi, Matthew J. Wakefield et al.|Nature Communications|2019Cited by 191
Therapeutic options for mucinous ovarian carcinomaKylie L. Gorringe, Clare L. Scott, Dane Cheasley et al.|Gynecologic Oncology|2020Cited by 95
Paragon (ANZGOG-0903)Anthony Bonaventura, Michael Friedländer, Rachel O’Connell et al.|International Journal of Gynecological Cancer|2017Cited by 22